
This study aimed to elucidate the independent, sex-specific dose-response trajectories between serum uric acid (SUA) and phenotypic age acceleration (PhenoAgeAccel), while carefully accounting for concurrent metabolic confounding. Using multivariable linear regression and sex-stratified restricted cubic splines (RCS) in a large-scale cross-sectional cohort, we found that elevated SUA showed a robust inverse association with biological aging in both sexes upon comprehensive metabolic adjustment. However, the morphological trajectories exhibited profound sex divergence. Females demonstrated a continuous, strictly linear inverse association (β = −0.35 years per 100 μmol/L increment, P < 0.001). Conversely, males exhibited a highly significant biphasic non-linear trajectory (P for non-linearity <0.001) with a critical inflection point at 353.4 μmol/L. Below this threshold, SUA was associated with a steep deceleration of biological aging (β = −2.13, P < 0.001); beyond it, this inverse association attenuated but remained highly significant (β = −0.94, P < 0.001), indicating diminishing marginal returns. Ultimately, physiologically elevated SUA is independently associated with lower biological aging metrics, a relationship that is frequently eclipsed by concomitant metabolic disorders. These distinct sex-specific trajectories challenge the traditional “the lower the better” clinical paradigm, suggesting that maintaining physiologically appropriate urate levels may be relevant for biological age management, though future prospective studies are needed to rule out reverse causality.
BACKGROUND Aging is shaped by a complex interplay of metabolic, behavioral, and environmental factors. DNA methylation (DNAm)-based epigenetic clocks provide accurate estimates of biological age and overall health, making them valuable tools for studying aging-related biomarkers and determinants. OBJECTIVES To construct a mortality-trained aging score (IDMAge) by integrating ten established DNAm clocks and apply it to systematically identify biomarkers and external factors associated with accelerated or decelerated aging and explore potential causal relationships. METHODS Using exposome-wide association analyses and elastic net regression, we evaluated associations between IDMAge and 102 exposures, identifying 22 significant factors, including glucose levels and smoking. We further employed Mendelian randomization with genome-wide association study data, alongside additional epigenetic clocks, to infer causal links between these exposures and aging acceleration. Dose-response relationships were assessed using restricted cubic spline models. RESULTS Using NHANES data, IDMAge outperformed individual estimators, showing strong correlations with chronological age, mortality risk, reduced survival, and elevated risk of conditions such as heart disease. Notably, we observed associations between glucose and aging-related outcomes, supported by indirect evidence from MR analyses. Similar associations were observed in the CHARLS and HRS cohorts using a distinct measure of physiological aging, providing supportive cross-cohort evidence. CONCLUSION IDMAge was associated with mortality and multiple exposomic factors. Although neither approach provided direct validation, both MR and analyses in CHARLS and HRS revealed consistent patterns supporting a potential role for glucose in aging-related decline. Future research should focus on strategies to slow aging and improve resilience in aging populations.
Background Adverse childhood experiences (ACEs) are associated with chronic diseases, but evidence regarding their impact on cardiovascular, kidney, and liver (CKL) diseases and multimorbidity remains limited. This study examines the association between ACEs and the onset of CKL diseases, and explores the potential mediating role of depressive symptoms. Methods The study included 7184 middle-aged and older adults aged ≥45 years without CKL disease at baseline from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2018). Cox models were used to assess the association between ACEs and new-onset disease; multistate models were employed to analyse the risk of disease transition; mediation analysis was conducted to examine the mediating role of depressive symptoms. Two-sample Mendelian randomization was further applied as an independent triangulation analysis of the association between genetic liability to depression and selected outcomes. Results During a median follow-up of 84 months, there were 1428, 547, 379 and 300 new cases of CVD, CKD, CLD and CKL multimorbidity, respectively. The risk of CVD, CKD, CLD and CKL multimorbidity was increased by 30% [95% confidence interval (CI): 1.15, 1.45], 37% (95% CI: 1.13, 1.66), 35% (95% CI: 1.07, 1.70) and 46% (95% CI: 1.12, 1.89), respectively, with a graded association observed across ACE categories (all P-trend <0.05). ACEs were significantly associated with the initial transition from health to CKL disease. Depressive symptoms acted as a potential mediator, and Mendelian randomization provided genetic evidence on the association between depression and selected cardiovascular outcomes. Conclusion ACEs were associated with higher risks of CVD, CKD, CLD and CKL multimorbidity in middle-aged and older adults, with depressive symptoms as a potential mediator. ACE history and depressive symptoms may help identify high-risk individuals, supporting further exploration of integrated management strategies for chronic diseases.
Sarcopenia is characterized by progressive loss of skeletal muscle strength, mass, and function during aging, driven by impaired proteostasis, mitochondrial dysfunction, altered metabolism, regenerative failure, and neuromuscular decline. Experimental models are needed to determine how these processes drive muscle degeneration and identify testable therapeutic mechanisms. Zebrafish combine whole-animal physiology with genetic manipulation, live imaging, and scalable phenotypic analysis, making them well suited to this purpose. Natural-aging, telomerase-deficient, dexamethasone-induced, high-fat-diet, and genetically defined zebrafish models each reproduce distinct structural, functional, metabolic, regenerative, or neuromuscular changes relevant to sarcopenia. In this Review, we compare study designs, measured endpoints, and mechanistic evidence to distinguish age-associated phenotypes from responses to induced stresses or defined molecular perturbations. Natural-aging models capture spontaneous age-associated changes in muscle structure, performance, and mitochondrial integrity; telomerase-deficient models reveal defects in tissue maintenance and regeneration; and dexamethasone- and high-fat-diet-induced models enable controlled analysis of proteostatic and metabolic stress. Genetic models directly test relationships between molecular perturbations and muscle phenotypes. Current studies, however, have notable limitations: swimming performance reflects whole-animal physiology rather than muscle strength, many markers do not directly measure pathway activity, and some models represent specific stress rather than primary sarcopenia. Across these models, shared phenotypes do not establish a common causal mechanism; model-specific findings require validation during natural aging and in mammalian and human studies.
Background Adiposity has pernicious health implications, notably contributing to cognitive decline and neuroanatomical alterations. Research regarding which measures of adiposity are most related to cognition and the brain is inconsistent. This study explores the relationships between 1) multiple adiposity measures, 2) adiposity measures and cognitive screening performance, and 3) adiposity measures and a machine-learning predicted brain age gap (BAG). Methods Cross-sectional data were combined from two multi-site studies, including 641 non-Hispanic black and non-Hispanic white adults (45–85 years old). Adiposity measures included Body Mass Index (BMI), waist circumference (WC), waist-to-hip ratio (WHpR), waist-to-height ratio (WHtR), and A Body Shape Index (ABSI) z-score. Cognition was assessed using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). MoCA scores were converted to equivalent MMSE scores. The predicted BAG was obtained using DeepBrainNet (n = 204) from T1-weighted brain MRI. Results Adiposity measures were significantly correlated, except for BMI and ABSI. After covariate adjustment, cognitive screening associations were small and inconsistent, with a linear association for BMI and nonlinear associations for WC and WHtR. BAG associations depended on model form, with nonlinear patterns for BMI, WC, and WHtR and higher predicted BAG at higher versus intermediate adiposity levels. Combining adiposity measures showed little additional predictive value. Conclusions Anthropometric adiposity measures, particularly BMI, WC, and WHtR, were more consistently related to MRI-derived brain age gap than to brief cognitive screening performance in a cohort of middle-aged and older adults. These findings describe cross-sectional associations with older predicted brain age, especially at higher adiposity levels.